The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by HighTower Advisors LLC

HighTower Advisors LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.7% in the third quarter, Holdings Channel.com reports. The fund owned 20,506 shares of the medical device company’s stock after purchasing an additional 2,155 shares during the period. HighTower Advisors LLC’s holdings in Cooper Companies were worth $2,261,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Point72 Asset Management L.P. boosted its position in shares of Cooper Companies by 480.1% during the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock worth $81,870,000 after purchasing an additional 776,140 shares during the period. Victory Capital Management Inc. lifted its stake in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. Magnetar Financial LLC purchased a new position in shares of Cooper Companies during the second quarter worth $63,822,000. TD Asset Management Inc acquired a new stake in shares of Cooper Companies in the second quarter valued at $53,045,000. Finally, Impax Asset Management Group plc raised its holdings in shares of Cooper Companies by 31.0% in the 2nd quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after buying an additional 558,886 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

COO has been the subject of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Morgan Stanley dropped their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Citigroup reduced their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Stifel Nicolaus restated a “buy” rating and issued a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $94.85 on Friday. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market cap of $18.93 billion, a P/E ratio of 48.64, a PEG ratio of 2.52 and a beta of 0.97. The firm has a fifty day moving average price of $103.49 and a 200 day moving average price of $98.87.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter last year, the company earned $0.87 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.